Patents by Inventor David C. Lundmark

David C. Lundmark has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210097286
    Abstract: An augmented reality viewer includes components, assemblies, and executable logic to provide a user with the perception of rich augmented reality experiences, including aspects of the aquatic world.
    Type: Application
    Filed: July 24, 2020
    Publication date: April 1, 2021
    Applicant: Magic Leap, Inc.
    Inventors: Daniel LeWinn LEHRICH, David C. Lundmark
  • Publication number: 20200409146
    Abstract: An augmented reality display system includes an electromagnetic field emitter to emit a known magnetic field in a known coordinate system. The system also includes an electromagnetic sensor to measure a parameter related to a magnetic flux at the electromagnetic sensor resulting from the known magnetic field. The system further includes a depth sensor to measure a distance in the known coordinate system. Moreover, the system includes a controller to determine pose information of the electromagnetic sensor relative to the electromagnetic field emitter in the known coordinate system based at least in part on the parameter related to the magnetic flux measured by the electromagnetic sensor and the distance measured by the depth sensor. In addition, the system includes a display system to display virtual content to a user based at least in part on the pose information of the electromagnetic sensor relative to the electromagnetic field emitter.
    Type: Application
    Filed: September 16, 2020
    Publication date: December 31, 2020
    Applicant: Magic Leap, Inc.
    Inventors: Samuel A. Miller, Michael J. Woods, David C. Lundmark
  • Patent number: 10838207
    Abstract: An augmented reality display system includes an electromagnetic field emitter to emit a known magnetic field in a known coordinate system. The system also includes an electromagnetic sensor to measure a parameter related to a magnetic flux at the electromagnetic sensor resulting from the known magnetic field. The system further includes a depth sensor to measure a distance in the known coordinate system. Moreover, the system includes a controller to determine pose information of the electromagnetic sensor relative to the electromagnetic field emitter in the known coordinate system based at least in part on the parameter related to the magnetic flux measured by the electromagnetic sensor and the distance measured by the depth sensor. In addition, the system includes a display system to display virtual content to a user based at least in part on the pose information of the electromagnetic sensor relative to the electromagnetic field emitter.
    Type: Grant
    Filed: December 14, 2018
    Date of Patent: November 17, 2020
    Assignee: MAGIC LEAP, INC.
    Inventors: Samuel A. Miller, Michael J. Woods, David C. Lundmark
  • Publication number: 20200351537
    Abstract: The invention provides a content provisioning system. A mobile device has a mobile device processor. The mobile device mobile device has communication interface connected to the mobile device processor and a first resource device communication interface and under the control of the mobile device processor to receive first content transmitted by the first resource device transmitter The mobile device mobile device has a mobile device output device connected to the mobile device processor and under control of the mobile device processor capable of providing an output that can be sensed by a user.
    Type: Application
    Filed: May 1, 2020
    Publication date: November 5, 2020
    Applicant: Magic Leap, Inc.
    Inventors: Eric C. BROWY, Andrew RABINOVICH, David C. LUNDMARK
  • Publication number: 20200192094
    Abstract: An augmented reality display system includes an electromagnetic field emitter to emit a known magnetic field in a known coordinate system. The system also includes an electromagnetic sensor to measure a parameter related to a magnetic flux at the electromagnetic sensor resulting from the known magnetic field. The system further includes a depth sensor to measure a distance in the known coordinate system. Moreover, the system includes a controller to determine pose information of the electromagnetic sensor relative to the electromagnetic field emitter in the known coordinate system based at least in part on the parameter related to the magnetic flux measured by the electromagnetic sensor and the distance measured by the depth sensor. In addition, the system includes a display system to display virtual content to a user based at least in part on the pose information of the electromagnetic sensor relative to the electromagnetic field emitter.
    Type: Application
    Filed: December 14, 2018
    Publication date: June 18, 2020
    Applicant: MAGIC LEAP, INC.
    Inventors: Samuel A. Miller, Michael J. Woods, David C. Lundmark
  • Patent number: 10678324
    Abstract: An augmented reality display system includes an electromagnetic field emitter to emit a known magnetic field in a known coordinate system. The system also includes an electromagnetic sensor to measure a parameter related to a magnetic flux at the electromagnetic sensor resulting from the known magnetic field. The system further includes a depth sensor to measure a distance in the known coordinate system. Moreover, the system includes a controller to determine pose information of the electromagnetic sensor relative to the electromagnetic field emitter in the known coordinate system based at least in part on the parameter related to the magnetic flux measured by the electromagnetic sensor and the distance measured by the depth sensor. In addition, the system includes a display system to display virtual content to a user based at least in part on the pose information of the electromagnetic sensor relative to the electromagnetic field emitter.
    Type: Grant
    Filed: December 14, 2018
    Date of Patent: June 9, 2020
    Assignee: Magic Leap, Inc.
    Inventors: Samuel A. Miller, Michael J. Woods, David C. Lundmark
  • Publication number: 20200139151
    Abstract: Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells.
    Type: Application
    Filed: January 15, 2020
    Publication date: May 7, 2020
    Applicant: Circuit Therapeutics, Inc.
    Inventors: David C. Lundmark, Fred Moll, Alexander K. Arrow
  • Publication number: 20200009397
    Abstract: Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells.
    Type: Application
    Filed: June 12, 2019
    Publication date: January 9, 2020
    Applicant: Circuit Therapeutics, Inc.
    Inventors: David C. Lundmark, Karl Deisseroth, Fred Moll, Dan Andersen, Alexander K. Arrow
  • Publication number: 20190369383
    Abstract: One embodiment is directed to a head-wearable viewing component for presenting virtual image information to a user, comprising: a head wearable frame; a left optical element for a left eye of the user, the left optical element coupled to the head wearable frame and comprising a left fluid/membrane lens configured to have an electromechanically adjustable focal length for the left eye of the user; a right optical element for a right eye of the user, the right optical element coupled to the head wearable frame and comprising a right fluid/membrane lens configured to have an electromechanically adjustable focal length for the right eye of the user; and a controller operatively coupled to the left optical element and right optical element and configured to provide one or more
    Type: Application
    Filed: May 30, 2019
    Publication date: December 5, 2019
    Applicant: Magic Leap, Inc.
    Inventors: Bach NGUYEN, David C. Lundmark
  • Publication number: 20190240500
    Abstract: Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitve proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells.
    Type: Application
    Filed: April 18, 2019
    Publication date: August 8, 2019
    Applicant: Circuit Therapeutics, Inc.
    Inventors: David C. Lundmark, Karl Deisseroth, Fred Moll, Dan Andersen, Alexander K. Arrow
  • Publication number: 20190155374
    Abstract: An augmented reality display system includes an electromagnetic field emitter to emit a known magnetic field in a known coordinate system. The system also includes an electromagnetic sensor to measure a parameter related to a magnetic flux at the electromagnetic sensor resulting from the known magnetic field. The system further includes a depth sensor to measure a distance in the known coordinate system. Moreover, the system includes a controller to determine pose information of the electromagnetic sensor relative to the electromagnetic field emitter in the known coordinate system based at least in part on the parameter related to the magnetic flux measured by the electromagnetic sensor and the distance measured by the depth sensor. In addition, the system includes a display system to display virtual content to a user based at least in part on the pose information of the electromagnetic sensor relative to the electromagnetic field emitter.
    Type: Application
    Filed: December 14, 2018
    Publication date: May 23, 2019
    Applicant: MAGIC LEAP, INC.
    Inventors: Samuel A. Miller, Michael J. Woods, David C. Lundmark
  • Publication number: 20190117993
    Abstract: Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells.
    Type: Application
    Filed: January 2, 2019
    Publication date: April 25, 2019
    Applicant: Circuit Therapeutics, Inc.
    Inventors: David C. Lundmark, Karl Deisseroth, Fred Moll, Dan Andersen, Alexander K. Arrow
  • Publication number: 20190105507
    Abstract: Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells.
    Type: Application
    Filed: December 11, 2018
    Publication date: April 11, 2019
    Applicant: Circuit Therapeutics, Inc.
    Inventors: Greg Stahler, Dan Andersen, Joyce Huang, David C. Lundmark, David Moore
  • Publication number: 20190099611
    Abstract: Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells.
    Type: Application
    Filed: December 10, 2018
    Publication date: April 4, 2019
    Applicant: Circuit Therapeutics, Inc.
    Inventors: David C. Lundmark, Fred Moll, Alexander K. Arrow
  • Patent number: 10213617
    Abstract: Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells.
    Type: Grant
    Filed: July 28, 2014
    Date of Patent: February 26, 2019
    Assignee: Circuit Therapeutics, Inc.
    Inventors: David C. Lundmark, Karl Deisseroth, Fred Moll, Dan Andersen, Alexander K. Arrow
  • Publication number: 20190038908
    Abstract: Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells.
    Type: Application
    Filed: October 19, 2018
    Publication date: February 7, 2019
    Applicant: Circuit Therapeutics, Inc.
    Inventors: David C. Lundmark, Karl Deisseroth, Fred Moll, Dan Andersen, Alexander K. Arrow
  • Patent number: 10188870
    Abstract: Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells.
    Type: Grant
    Filed: July 31, 2014
    Date of Patent: January 29, 2019
    Assignee: Circuit Therapeutics, Inc.
    Inventors: David C. Lundmark, Fred Moll, Alexander K. Arrow
  • Publication number: 20190015677
    Abstract: Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells.
    Type: Application
    Filed: September 18, 2018
    Publication date: January 17, 2019
    Applicant: Circuit Therapeutics, Inc.
    Inventors: Greg Stahler, Dan Andersen, Joyce Huang, David C. Lundmark, David Moore
  • Patent number: 10180734
    Abstract: An augmented reality display system includes an electromagnetic field emitter to emit a known magnetic field in a known coordinate system. The system also includes an electromagnetic sensor to measure a parameter related to a magnetic flux at the electromagnetic sensor resulting from the known magnetic field. The system further includes a depth sensor to measure a distance in the known coordinate system. Moreover, the system includes a controller to determine pose information of the electromagnetic sensor relative to the electromagnetic field emitter in the known coordinate system based at least in part on the parameter related to the magnetic flux measured by the electromagnetic sensor and the distance measured by the depth sensor. In addition, the system includes a display system to display virtual content to a user based at least in part on the pose information of the electromagnetic sensor relative to the electromagnetic field emitter.
    Type: Grant
    Filed: February 6, 2017
    Date of Patent: January 15, 2019
    Assignee: MAGIC LEAP, INC.
    Inventors: Samuel A. Miller, Michael J. Woods, David C. Lundmark
  • Publication number: 20180345033
    Abstract: Configurations are described for utilizing light-activated proteins within cell membranes and subcellular regions to assist with medical treatment paradigms, such as hypertension treatment via anatomically specific and temporally precise modulation of renal plexus activity. The invention provides for proteins, nucleic acids, vectors and methods for genetically targeted expression of light-sensitive proteins to specific cells or defined cell populations. In particular the invention provides systems, devices, and methods for millisecond-timescale temporal control of certain cell activities using moderate light intensities, such as the generation or inhibition of electrical spikes in nerve cells and other excitable cells.
    Type: Application
    Filed: June 13, 2018
    Publication date: December 6, 2018
    Applicant: Circuit Therapeutics, Inc.
    Inventors: David C. Lundmark, Fred Moll, Alexander K. Arrow